PRECIGEN, INC. Amortization of Intangible Assets
PRECIGEN, INC. (PGEN) reported Amortization of Intangible Assets of $319.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-04
- PRECIGEN, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $319.00K, a 0.31% increase year-over-year.
- PRECIGEN, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $318.00K, a 0.31% decline year-over-year.
- PRECIGEN, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $318.00K, a 0.00% change year-over-year.
- PRECIGEN, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $318.00K, a 0.00% change year-over-year.
- PRECIGEN, INC. amortization of intangible assets for fiscal 2025 was $1.27M, a 58.39% decline from fiscal 2024.
- PRECIGEN, INC. amortization of intangible assets for fiscal 2024 was $3.06M, a 36.90% decline from fiscal 2023.
- PRECIGEN, INC. amortization of intangible assets for fiscal 2023 was $4.85M, a 1.04% increase from fiscal 2022.
- PRECIGEN, INC. amortization of intangible assets for fiscal 2022 was $4.80M, a 9.01% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $319.00K 10-Q · filed 2026-08-04 | $637.00K 10-Q · filed 2026-08-04 | $955.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.27M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $318.00K 10-Q · filed 2026-05-13 | $636.00K derived: sum of 2 quarters · filed 2026-05-13 | $954.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.27M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $318.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $636.00K derived: sum of 2 quarters · filed 2026-03-25 | $954.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.27M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $318.00K 10-Q · filed 2025-11-13 | $636.00K derived: sum of 2 quarters · filed 2026-08-04 | $955.00K 10-Q · filed 2025-11-13 | $1.27M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $318.00K 10-Q · filed 2026-08-04 | $637.00K 10-Q · filed 2026-08-04 | $955.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.27M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $319.00K 10-Q · filed 2026-05-13 | $637.00K derived: sum of 2 quarters · filed 2026-05-13 | $955.00K derived: sum of 3 quarters · filed 2026-05-13 | $2.16M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $318.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $636.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.84M derived: sum of 3 quarters · filed 2026-03-25 | $3.06M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $318.00K 10-Q · filed 2025-11-13 | $1.53M derived: sum of 2 quarters · filed 2025-11-13 | $2.74M 10-Q · filed 2025-11-13 | $3.95M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-06-30 | $1.21M 10-Q · filed 2025-08-12 | $2.42M 10-Q · filed 2025-08-12 | $3.63M derived: sum of 3 quarters · filed 2026-03-25 | $4.85M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-03-31 | $1.22M 10-Q · filed 2025-05-14 | $2.42M derived: sum of 2 quarters · filed 2026-03-25 | $3.64M derived: sum of 3 quarters · filed 2026-03-25 | $4.86M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2023-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $2.43M derived: sum of 2 quarters · filed 2026-03-25 | $3.64M derived: sum of 3 quarters · filed 2026-03-25 | $4.85M 10-K · filed 2026-03-25 | ||||
| 2023-09-30 | $1.22M 10-Q · filed 2024-11-14 | $2.44M derived: sum of 2 quarters · filed 2024-11-14 | $3.64M 10-Q · filed 2024-11-14 | $4.80M derived: sum of 4 quarters · filed 2025-03-19 | ||||
| 2023-06-30 | $1.22M 10-Q · filed 2024-08-14 | $2.42M 10-Q · filed 2024-08-14 | $3.58M derived: sum of 3 quarters · filed 2025-03-19 | $4.74M derived: sum of 4 quarters · filed 2025-03-19 | ||||
| 2023-03-31 | $1.21M 10-Q · filed 2024-05-14 | $2.37M derived: sum of 2 quarters · filed 2025-03-19 | $3.52M derived: sum of 3 quarters · filed 2025-03-19 | $4.74M derived: sum of 4 quarters · filed 2025-03-19 | ||||
| 2022-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $2.31M derived: sum of 2 quarters · filed 2025-03-19 | $3.53M derived: sum of 3 quarters · filed 2025-03-19 | $4.80M 10-K · filed 2025-03-19 | ||||
| 2022-09-30 | $1.15M 10-Q · filed 2023-11-09 | $2.37M derived: sum of 2 quarters · filed 2023-11-09 | $3.64M 10-Q · filed 2023-11-09 | $4.92M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-06-30 | $1.22M 10-Q · filed 2023-08-09 | $2.48M 10-Q · filed 2023-08-09 | $3.77M derived: sum of 3 quarters · filed 2024-03-19 | $5.08M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-03-31 | $1.26M 10-Q · filed 2023-05-10 | $1.81M 10-Q · filed 2022-05-09 | $2.55M derived: sum of 2 quarters · filed 2024-03-19 | $3.86M derived: sum of 3 quarters · filed 2024-03-19 | $5.20M derived: sum of 4 quarters · filed 2024-03-19 | |||
| 2021-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $2.60M derived: sum of 2 quarters · filed 2024-03-19 | $3.94M derived: sum of 3 quarters · filed 2024-03-19 | $5.27M 10-K · filed 2024-03-19 | $7.56M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $1.31M 10-Q · filed 2022-11-09 | $1.87M 10-Q · filed 2021-11-08 | $2.65M derived: sum of 2 quarters · filed 2022-11-09 | $3.99M 10-Q · filed 2022-11-09 | $5.73M 10-Q · filed 2021-11-08 | $4.15M derived: sum of 4 quarters · filed 2023-03-06 | ||
| 2021-06-30 | $1.34M 10-Q · filed 2022-08-08 | $1.93M 10-Q · filed 2021-08-09 | $2.68M 10-Q · filed 2022-08-08 | $3.86M 10-Q · filed 2021-08-09 | $2.83M derived: sum of 3 quarters · filed 2023-03-06 | $4.75M derived: sum of 4 quarters · filed 2023-03-06 | ||
| 2021-03-31 | $1.93M 10-Q · filed 2022-05-09 | $1.50M derived: sum of 2 quarters · filed 2023-03-06 | $3.41M derived: sum of 3 quarters · filed 2023-03-06 | $5.29M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2020-12-31 | -$432.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $1.48M derived: sum of 2 quarters · filed 2023-03-06 | $3.36M derived: sum of 3 quarters · filed 2023-03-06 | $5.24M 10-K · filed 2023-03-06 | $7.59M 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $1.91M 10-Q · filed 2021-11-08 | $3.80M derived: sum of 2 quarters · filed 2021-11-08 | $5.67M 10-Q · filed 2021-11-08 | $7.61M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $1.88M 10-Q · filed 2021-08-09 | $3.76M 10-Q · filed 2021-08-09 | $5.70M derived: sum of 3 quarters · filed 2022-03-01 | $7.59M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $1.88M 10-Q · filed 2021-05-10 | $3.81M derived: sum of 2 quarters · filed 2022-03-01 | $5.70M derived: sum of 3 quarters · filed 2022-03-01 | $7.63M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.82M derived: sum of 2 quarters · filed 2022-03-01 | $5.75M derived: sum of 3 quarters · filed 2022-03-01 | $7.92M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $1.89M 10-Q · filed 2020-11-09 | $2.73M 10-Q · filed 2019-11-12 | $3.82M derived: sum of 2 quarters · filed 2020-11-09 | $5.99M 10-Q · filed 2020-11-09 | $8.50M 10-Q · filed 2019-11-12 | $3.18M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $1.93M 10-Q · filed 2020-08-10 | $2.77M 10-Q · filed 2019-08-09 | $4.10M 10-Q · filed 2020-08-10 | $5.77M 10-Q · filed 2019-08-09 | $1.29M derived: sum of 3 quarters · filed 2021-03-01 | $5.98M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | $2.17M 10-Q · filed 2020-05-11 | $3.00M 10-Q · filed 2019-05-09 | -$640.00K derived: sum of 2 quarters · filed 2021-03-01 | $4.05M derived: sum of 3 quarters · filed 2021-03-01 | $8.91M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.88M derived: sum of 2 quarters · filed 2021-03-01 | $6.74M derived: sum of 3 quarters · filed 2021-03-01 | $11.67M 10-K · filed 2021-03-01 | $18.78M 10-K · filed 2019-03-01 | |||
| 2018-09-30 | $4.69M 10-Q · filed 2019-11-12 | $9.55M derived: sum of 2 quarters · filed 2019-11-12 | $14.47M 10-Q · filed 2019-11-12 | $11.69M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | $4.86M 10-Q · filed 2019-08-09 | $9.78M 10-Q · filed 2019-08-09 | $7.00M derived: sum of 3 quarters · filed 2020-03-02 | $12.00M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | $4.93M 10-Q · filed 2019-05-09 | $2.14M derived: sum of 2 quarters · filed 2020-03-02 | $7.14M derived: sum of 3 quarters · filed 2020-03-02 | $11.78M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | -$2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $2.21M derived: sum of 2 quarters · filed 2020-03-02 | $6.85M derived: sum of 3 quarters · filed 2020-03-02 | $11.47M 10-K · filed 2020-03-02 | $19.19M 10-K · filed 2018-03-01 | |||
| 2017-09-30 | $5.00M 10-Q · filed 2018-11-08 | $9.64M derived: sum of 2 quarters · filed 2018-11-08 | $14.26M 10-Q · filed 2018-11-08 | $18.55M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $4.64M 10-Q · filed 2018-08-13 | $9.26M 10-Q · filed 2018-08-13 | $13.55M derived: sum of 3 quarters · filed 2019-03-01 | $17.20M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $4.62M 10-Q/A · filed 2018-08-13 | $8.91M derived: sum of 2 quarters · filed 2019-03-01 | $12.57M derived: sum of 3 quarters · filed 2019-03-01 | $16.29M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $7.95M derived: sum of 2 quarters · filed 2019-03-01 | $11.67M derived: sum of 3 quarters · filed 2019-03-01 | $15.19M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | $3.65M 10-Q · filed 2017-11-09 | $7.37M derived: sum of 2 quarters · filed 2017-11-09 | $10.89M 10-Q · filed 2017-11-09 | $14.32M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $3.72M 10-Q · filed 2017-08-09 | $7.24M 10-Q · filed 2017-08-09 | $10.67M derived: sum of 3 quarters · filed 2018-03-01 | $13.53M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $3.52M 10-Q · filed 2017-05-10 | $6.95M derived: sum of 2 quarters · filed 2018-03-01 | $9.81M derived: sum of 3 quarters · filed 2018-03-01 | $11.79M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $6.29M derived: sum of 2 quarters · filed 2018-03-01 | $8.28M derived: sum of 3 quarters · filed 2018-03-01 | $9.87M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $2.86M 10-Q · filed 2016-11-09 | $4.84M derived: sum of 2 quarters · filed 2016-11-09 | $6.43M 10-Q · filed 2016-11-09 | $8.01M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $1.98M 10-Q · filed 2016-08-09 | $3.58M 10-Q · filed 2016-08-09 | $5.15M derived: sum of 3 quarters · filed 2017-03-01 | $6.44M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $1.60M 10-Q · filed 2016-05-10 | $3.17M derived: sum of 2 quarters · filed 2017-03-01 | $4.46M derived: sum of 3 quarters · filed 2017-03-01 | $5.15M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $2.86M derived: sum of 2 quarters · filed 2017-03-01 | $3.55M derived: sum of 3 quarters · filed 2017-03-01 | $4.24M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $1.29M 10-Q · filed 2015-11-09 | $1.98M derived: sum of 2 quarters · filed 2015-11-09 | $2.66M 10-Q · filed 2015-11-09 | $3.40M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $687.00K 10-Q · filed 2015-08-10 | $1.37M 10-Q · filed 2015-08-10 | $2.11M derived: sum of 3 quarters · filed 2016-02-29 | $2.82M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $687.00K 10-Q · filed 2015-05-11 | $1.42M derived: sum of 2 quarters · filed 2016-02-29 | $2.13M derived: sum of 3 quarters · filed 2016-02-29 | $2.84M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $737.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.45M derived: sum of 2 quarters · filed 2016-02-29 | $2.15M derived: sum of 3 quarters · filed 2016-02-29 | $2.88M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $709.00K 10-Q · filed 2014-11-13 | $1.42M derived: sum of 2 quarters · filed 2014-08-14 | $2.14M 10-Q · filed 2014-11-13 | $2.90M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | $709.00K 10-Q · filed 2014-08-14 | $1.43M 10-Q · filed 2014-08-14 | $2.19M derived: sum of 3 quarters · filed 2015-03-02 | $2.95M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $725.00K 10-Q · filed 2014-05-09 | $1.48M derived: sum of 2 quarters · filed 2015-03-02 | $2.24M derived: sum of 3 quarters · filed 2015-03-02 | $3.00M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $757.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $1.51M derived: sum of 2 quarters · filed 2015-03-02 | $2.27M derived: sum of 3 quarters · filed 2015-03-02 | $3.03M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $756.00K 10-Q · filed 2013-11-07 | $1.51M derived: sum of 2 quarters · filed 2013-11-07 | $2.27M 10-Q · filed 2013-11-07 | |||||
| 2012-06-30 | $757.00K 10-Q/A · filed 2013-10-21 | $1.51M 10-Q/A · filed 2013-10-21 | ||||||
| 2011-12-31 | $1.26M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |